Boston, MA, United States of America

Socheata Ly

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Massachusetts. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Socheata Ly. Retrieved from https://idiyas.com/inventor/socheata-ly-ugumhgz7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Socheata Ly: Innovator in SARS-CoV-2 Modulation

Introduction

Socheata Ly is a prominent inventor based in Boston, MA, who has made significant contributions to the field of biotechnology. With a focus on combating viral infections, her work has garnered attention for its potential impact on public health.

Latest Patents

Socheata Ly holds a patent for "Oligonucleotides for SARS-CoV-2 modulation." This patent relates to novel SARS-CoV-2 targeting sequences, providing innovative oligonucleotides aimed at the treatment of SARS-CoV-2 infection. Her research offers promising avenues for therapeutic interventions against COVID-19.

Career Highlights

Socheata Ly is affiliated with the University of Massachusetts, where she continues to advance her research in molecular biology and virology. Her academic background and expertise have positioned her as a key figure in the fight against viral diseases.

Collaborations

Socheata has collaborated with notable colleagues, including Anastasia Khvorova and Jonathan Watts, who share her commitment to advancing scientific knowledge and developing effective treatments.

Conclusion

Socheata Ly's innovative work in the development of SARS-CoV-2 targeting oligonucleotides highlights her dedication to addressing critical health challenges. Her contributions are paving the way for future advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…